HOPKINTON, Mass., May 11, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a partnership
"We are pleased to become the first UK-based sequencing center to implement Caliper's suite of next generation sequencing tools," said Dr Melanie Febrer, TGAC's Library Construction Manager. "These automated solutions will enable us to develop a high throughput system for both sample preparation and post library processes."
"We are excited to be working with TGAC," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper's automated solutions for sample preparation are uniquely capable of providing the sensitivity and reproducibility necessary for sequencing sample processing. Our solutions have been widely adopted by the sequencing community and partnerships with pioneering groups like TGAC are critical to the development of solutions that advance our understanding of disease."
Caliper has developed a complete suite of next generation sequencing tools including the Sciclone® NGS Workstation for library construction and sequence capture protocols, the high throughput LabChip® GX for library quantification and quality control, and the preparative LabChip XT that replaces the tedious and inconsistent gel isolation steps for library preparation. For additional information about Caliper's solutions for high throughput sequencing, please visit www.caliperls.com/genomics.
About The Genome Analysis Centre (TGAC)
The Genome Analysis Centre is a national genomics and bioinformatics centre which addresses problems in agriculture, sustainable energy, food and nutrition, through novel approaches in genomics and specializing in genomics technology, high throughput data analysis, advanced bioinformatics and innovation. TGAC was established by the Biotechnology and Biological Sciences Research Council in partnership with the East of England Development Agency (EEDA), Norfolk County Council, Norwich City Council, South Norfolk Council and the Greater Norwich Development Partnership. For more information please visit www.tgac.bbsrc.ac.uk.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
Caliper, LabChip, and Sciclone are registered trademarks of Caliper Life Sciences, Inc.
SOURCE Caliper Life Sciences, Inc.
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All